Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy
Abstract Background Resistance to anti-malarial drugs hinders efforts on malaria elimination and eradication. Following the global spread of chloroquine-resistant parasites, the Republic of Congo adopted artemisinin-based combination therapy (ACT) in 2006 as a first-line treatment for uncomplicated...
Published in: | Malaria Journal |
---|---|
Main Authors: | , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
BMC
2017
|
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-017-1816-x https://doaj.org/article/35b9427bb75349c4a5f957df450737ed |
id |
ftdoajarticles:oai:doaj.org/article:35b9427bb75349c4a5f957df450737ed |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:35b9427bb75349c4a5f957df450737ed 2023-05-15T15:17:04+02:00 Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy Felix Koukouikila-Koussounda Sankarganesh Jeyaraj Christian N. Nguetse Charles Nchotebah Nkonganyi Kossiwa Clarisse Kokou Mandingha K. Etoka-Beka Francine Ntoumi Thirumalaisamy P. Velavan 2017-04-01T00:00:00Z https://doi.org/10.1186/s12936-017-1816-x https://doaj.org/article/35b9427bb75349c4a5f957df450737ed EN eng BMC http://link.springer.com/article/10.1186/s12936-017-1816-x https://doaj.org/toc/1475-2875 doi:10.1186/s12936-017-1816-x 1475-2875 https://doaj.org/article/35b9427bb75349c4a5f957df450737ed Malaria Journal, Vol 16, Iss 1, Pp 1-7 (2017) Malaria Plasmodium falciparum Pfcrt Pfmdr1 Pfatp6 Pfk13 Arctic medicine. Tropical medicine RC955-962 Infectious and parasitic diseases RC109-216 article 2017 ftdoajarticles https://doi.org/10.1186/s12936-017-1816-x 2022-12-31T02:19:23Z Abstract Background Resistance to anti-malarial drugs hinders efforts on malaria elimination and eradication. Following the global spread of chloroquine-resistant parasites, the Republic of Congo adopted artemisinin-based combination therapy (ACT) in 2006 as a first-line treatment for uncomplicated malaria. To assess the impacts after implementation of ACT, a molecular surveillance for anti-malarial drug resistance was conducted in Congo 4 and 9 years after the introduction of ACT. Methods Blood samples of 431 febrile children aged 1–10 years were utilized from two previous studies conducted in 2010 (N = 311) and 2015 (N = 120). All samples were screened for malaria parasites using nested PCR. Direct sequencing was used to determine the frequency distribution of genetic variants in the anti-malarial drug-resistant Plasmodium falciparum genes (Pfcrt, Pfmdr1, Pfatp6, Pfk13) in malaria-positive isolates. Results One-hundred and nineteen (N = 70 from 2010 and N = 49 from 2015) samples were positive for P. falciparum. A relative decrease in the proportion of chloroquine-resistant haplotype (CVIET) from 100% in 2005, 1 year before the introduction and implementation of ACT in 2006, to 98% in 2010 to 71% in 2015 was observed. Regarding the multidrug transporter gene, a considerable reduction in the frequency of the mutations N86Y (from 73 to 27%) and D1246Y (from 22 to 0%) was observed. However, the prevalence of the Y184F mutation remained stable (49% in 2010 compared to 54% in 2015). Isolates carrying the Pfatp6 H243Y was 25% in 2010 and this frequency was reduced to null in 2015. None of the parasites harboured the Pfk13 mutations associated with prolonged artemisinin clearance in Southeast Asia. Nevertheless, 13 new Pfk13 variants are reported among the investigated isolates. Conclusion The implementation of ACT has led to the decline in prevalence of chloroquine-resistant parasites in the Republic of Congo. However, the constant prevalence of the PfMDR1 Y184F mutation, associated with lumefantrine susceptibility, ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Malaria Journal 16 1 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Malaria Plasmodium falciparum Pfcrt Pfmdr1 Pfatp6 Pfk13 Arctic medicine. Tropical medicine RC955-962 Infectious and parasitic diseases RC109-216 |
spellingShingle |
Malaria Plasmodium falciparum Pfcrt Pfmdr1 Pfatp6 Pfk13 Arctic medicine. Tropical medicine RC955-962 Infectious and parasitic diseases RC109-216 Felix Koukouikila-Koussounda Sankarganesh Jeyaraj Christian N. Nguetse Charles Nchotebah Nkonganyi Kossiwa Clarisse Kokou Mandingha K. Etoka-Beka Francine Ntoumi Thirumalaisamy P. Velavan Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy |
topic_facet |
Malaria Plasmodium falciparum Pfcrt Pfmdr1 Pfatp6 Pfk13 Arctic medicine. Tropical medicine RC955-962 Infectious and parasitic diseases RC109-216 |
description |
Abstract Background Resistance to anti-malarial drugs hinders efforts on malaria elimination and eradication. Following the global spread of chloroquine-resistant parasites, the Republic of Congo adopted artemisinin-based combination therapy (ACT) in 2006 as a first-line treatment for uncomplicated malaria. To assess the impacts after implementation of ACT, a molecular surveillance for anti-malarial drug resistance was conducted in Congo 4 and 9 years after the introduction of ACT. Methods Blood samples of 431 febrile children aged 1–10 years were utilized from two previous studies conducted in 2010 (N = 311) and 2015 (N = 120). All samples were screened for malaria parasites using nested PCR. Direct sequencing was used to determine the frequency distribution of genetic variants in the anti-malarial drug-resistant Plasmodium falciparum genes (Pfcrt, Pfmdr1, Pfatp6, Pfk13) in malaria-positive isolates. Results One-hundred and nineteen (N = 70 from 2010 and N = 49 from 2015) samples were positive for P. falciparum. A relative decrease in the proportion of chloroquine-resistant haplotype (CVIET) from 100% in 2005, 1 year before the introduction and implementation of ACT in 2006, to 98% in 2010 to 71% in 2015 was observed. Regarding the multidrug transporter gene, a considerable reduction in the frequency of the mutations N86Y (from 73 to 27%) and D1246Y (from 22 to 0%) was observed. However, the prevalence of the Y184F mutation remained stable (49% in 2010 compared to 54% in 2015). Isolates carrying the Pfatp6 H243Y was 25% in 2010 and this frequency was reduced to null in 2015. None of the parasites harboured the Pfk13 mutations associated with prolonged artemisinin clearance in Southeast Asia. Nevertheless, 13 new Pfk13 variants are reported among the investigated isolates. Conclusion The implementation of ACT has led to the decline in prevalence of chloroquine-resistant parasites in the Republic of Congo. However, the constant prevalence of the PfMDR1 Y184F mutation, associated with lumefantrine susceptibility, ... |
format |
Article in Journal/Newspaper |
author |
Felix Koukouikila-Koussounda Sankarganesh Jeyaraj Christian N. Nguetse Charles Nchotebah Nkonganyi Kossiwa Clarisse Kokou Mandingha K. Etoka-Beka Francine Ntoumi Thirumalaisamy P. Velavan |
author_facet |
Felix Koukouikila-Koussounda Sankarganesh Jeyaraj Christian N. Nguetse Charles Nchotebah Nkonganyi Kossiwa Clarisse Kokou Mandingha K. Etoka-Beka Francine Ntoumi Thirumalaisamy P. Velavan |
author_sort |
Felix Koukouikila-Koussounda |
title |
Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy |
title_short |
Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy |
title_full |
Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy |
title_fullStr |
Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy |
title_full_unstemmed |
Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy |
title_sort |
molecular surveillance of plasmodium falciparum drug resistance in the republic of congo: four and nine years after the introduction of artemisinin-based combination therapy |
publisher |
BMC |
publishDate |
2017 |
url |
https://doi.org/10.1186/s12936-017-1816-x https://doaj.org/article/35b9427bb75349c4a5f957df450737ed |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Malaria Journal, Vol 16, Iss 1, Pp 1-7 (2017) |
op_relation |
http://link.springer.com/article/10.1186/s12936-017-1816-x https://doaj.org/toc/1475-2875 doi:10.1186/s12936-017-1816-x 1475-2875 https://doaj.org/article/35b9427bb75349c4a5f957df450737ed |
op_doi |
https://doi.org/10.1186/s12936-017-1816-x |
container_title |
Malaria Journal |
container_volume |
16 |
container_issue |
1 |
_version_ |
1766347346858213376 |